Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

19 May 2008 07:00

RNS Number : 7168U
Wilmington Group Plc
19 May 2008
 



19 May 2008

Wilmington Group plc 

Interim Management Statement

Wilmington Group plc (the "Company"), the professional information and training group, today announces its Interim Management Statement for the period since 31 December 2007 up until the date of this announcement and incorporating the Company's third quarter ending 31 March 2008. 

Trading performance

Trading in the quarter to 31 March 2008, and for the subsequent period to the date of this announcement, has been in line with the board's expectations for the financial year.

The investment in the compliance programme in Singapore continues, with the development of course materials and the accreditation of the programmes progressing well. The next courses are expected to run in the first quarter of our next financial year and the level of interest in the courses is encouraging.

During the three months to 31 March 2008, the company spent £2.2m as part of its share buy back programme and £5.8m acquiring AP Information Services ("APIS"). Nonetheless, net debt at 31 March 2008 of £19.0m was only £4.2m more than in 31 December 2007, reflecting strong underlying cash flow from the business, which has continued to date.

We reported in February that we had acquired APIS, a leading provider of specialist information on pension funds and their advisors. Since then APIS has been relocated and fully integrated into Waterlow Professional Publishing. In April we completed the acquisition of Aspire which publishes International Pension Funds and their Advisors. The initial consideration was £1.3m satisfied in cash with up to a further £0.5m payable dependent on the performance of the business to June 2009.

Outlook

The business continues to benefit from the actions we have taken to focus our activities on professional business markets and develop our operations both organically and through selective bolt on acquisitions. We have committed bank facilities until 2012 and a modest level of gearing that will enable us to continue to underpin the development of our business with further bolt on acquisitions. We expect the strategies we have adopted to enable us to continue to make progress over the previous year and we expect the outcome for the current financial year to be in line with our expectations.

The acquisitions made during the current financial year are anticipated to deliver results in line with the board's expectations at the time of acquisition and to show further benefits during the next financial year.

 

-Ends-

For further information, please contact:

Wilmington Group Plc

Charles Brady, Chief Executive  020 7422 6800

Basil Brookes, Finance Director

Weber Shandwick Financial 020 7067 0700

Nick Oborne/ Hannah Marwood 

Notes to Editors

Wilmington Group plc is one of the UK's leading providers of information and training for professional business markets. The Group provides training, arranges industry events and publishes magazines, directories, databases and special reports focused primarily on its two principal sectors of Legal & Regulatory, and Business Information which comprises Healthcare and Media businesses. Capitalised at approximately £155 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUURGAUPRGMQ
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.